Unknown

Dataset Information

0

Repurposing Nucleoside Analogs for Human Coronaviruses.

ABSTRACT: Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or CoV-2). Some reports claimed certain nucleoside analogs to be active against CoV-2 and thus needed confirmation. Here, we evaluated a panel of compounds and identified novel nucleoside analogs with antiviral activity against CoV-2 and HCoV-OC43 while ruling out others. Of significance, sofosbuvir demonstrated no antiviral effect against CoV-2, and its triphosphate did not inhibit CoV-2 RNA polymerase.

SUBMITTER: Zandi K 

PROVIDER: S-EPMC7927863 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or CoV-2). Some reports claimed certain nucleoside analogs to be active against CoV-2 and thus needed confirmation. Here, we evaluated a panel of compounds and identified novel nucleoside analogs with antiviral activity against CoV-2 and HCoV-OC43 while ruling out others. Of significance, sofosbuvir demonstrated no antiviral effect against CoV-2, and its triphosphate did  ...[more]

Similar Datasets

Unknown Repurposing of the nucleoside analogs for influenza.
| S-EPMC12447893 | biostudies-literature
Unknown Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses.
| S-EPMC7918729 | biostudies-literature
Unknown Synthesis of Boron-Containing Nucleoside Analogs.
| S-EPMC10845115 | biostudies-literature
Transcriptomics The search for enzymes responsible for metabolism of nucleoside analogs
2005-10-30 | GSE1862 | GEO
Unknown Lipophilic Nucleoside Triphosphate Prodrugs of Anti-HIV Active Nucleoside Analogs as Potential Antiviral Compounds.
| S-EPMC10754118 | biostudies-literature
Unknown Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs.
| S-EPMC11430618 | biostudies-literature
Unknown Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
| S-EPMC7946546 | biostudies-literature
Unknown Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study.
| S-EPMC9797896 | biostudies-literature
Unknown Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
| S-EPMC6709485 | biostudies-literature
Unknown Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.
| S-EPMC2878035 | biostudies-literature